Home » Stocks » RMD

ResMed Inc. (RMD)

Stock Price: $206.53 USD -3.04 (-1.45%)
Updated November 24, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 29.93B
Revenue (ttm) 3.03B
Net Income (ttm) 679.90M
Shares Out 144.92M
EPS (ttm) 4.66
PE Ratio 44.32
Forward PE 43.29
Dividend $1.56
Dividend Yield 0.76%

Stock Quote

Trading Day November 24
Last Price $206.53
Previous Close $209.57
Change ($) -3.04
Change (%) -1.45%
Day's Open 211.00
Day's Range 204.79 - 211.00
Day's Volume 580,669
52-Week Range 108.85 - 224.24

More Stats

Market Cap 29.93B
Enterprise Value 30.70B
Earnings Date (est) Jan 28, 2021
Ex-Dividend Date Nov 10, 2020
Shares Outstanding 144.92M
Float 143.52M
EPS (basic) 4.70
EPS (diluted) 4.66
FCF / Share 4.82
Dividend $1.56
Dividend Yield 0.76%
Earnings Yield 2.26%
FCF Yield 2.33%
Payout Ratio 33.20%
Shares Short 1.34M
Short Ratio 2.63
Short % of Float 0.93%
Beta 0.28
PE Ratio 44.32
Forward PE 43.29
P/FCF Ratio 42.90
PS Ratio 9.88
PB Ratio 11.42
Revenue 3.03B
Operating Income 855.45M
Net Income 679.90M
Free Cash Flow 697.73M
Net Cash -767.52M
Net Cash / Share -5.30
Gross Margin 58.37%
Operating Margin 28.25%
Profit Margin 22.50%
FCF Margin 23.04%
ROA 12.22%
ROE 28.35%
ROIC 32.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (18)

Buy 5
Overweight 1
Hold 9
Underweight 0
Sell 3

Analyst Consensus: Overweight

Price Target

$192.72*
(-6.69% downside)
Low
145
Current: $206.53
High
218
Target: 192.72
*Average 12-month price target from 13 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue2,9572,6072,3402,0671,8391,6791,5551,5141,3691,243
Revenue Growth13.44%11.38%13.23%12.4%9.52%7.97%2.68%10.66%10.08%-
Gross Profit1,7181,4941,3351,2021,0661,011990941821741
Operating Income810579542426429409405355294267
Net Income622405316342352353345307255227
Shares Outstanding144143143141140140141143146152
Earnings Per Share4.272.802.192.402.492.472.392.101.711.44
EPS Growth52.5%27.85%-8.75%-3.61%0.81%3.35%13.81%22.81%18.75%-
Dividend Per Share1.561.481.401.321.201.121.000.68--
Dividend Growth5.41%5.71%6.06%10%7.14%12%47.06%---
Operating Cash Flow802459505414548383391403383283
Capital Expenditures-95.33-68.71-62.58-62.22-58.53-62.50-72.72-63.58-47.14-66.61
Free Cash Flow707390442352489321319339336217
Cash & Equivalents463147189822731717906876810735
Total Debt1,2991,2712811,0791,173301301301251100
Net Cash / Debt-836-1,124-92.75-257-441417605575559635
Assets4,5874,1083,0643,4683,2572,1822,3612,2112,1382,069
Liabilities2,0902,0351,0051,5081,562594603600530338
Book Value2,4972,0722,0591,9601,6951,5871,7581,6111,6081,731
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ResMed Inc.
Country United States
Employees 7,770
CEO Michael J. Farrell

Stock Information

Ticker Symbol RMD
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: RMD
IPO Date June 2, 1995

Description

ResMed develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.